Streptozocin (U-9889)
Catalog #
27656-2
$215
*
●
●
Purchase
Description
Antibiotic and antitumor agent. Alkylates DNA and induces diabetes mellitus via reduction of nicotinamide adenine dinucleotide in pancreatic β-cells in vivo.
●
Synonyms
Streptozotocin; U-9889; STZ; 1-methyl-1-nitroso-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
●
Product Data Gallery
Product Info
Storage and Usage
Citations
Purity
≥98% by HPLC
Formula
C8H15N3O7
MW
265.2 Da
Solubility
Soluble in water (50 mg/ml), ethanol (3 mg/ml), and DMSO (50 mg/ml). Solutions are not stable; release of NO gas occurs spontaneously at room temperature. Prepare solutions immediately before use.
CAS Registry #
18883-66-4
Background
Streptozocin, also known as streptozotocin and U-9889, is a small molecule, N-nitroso-containing antibiotic and a potent DNA methylating agent. Streptozocin acts as a nitric oxide (NO) donor and vasorelaxant. In rat cell studies, this compound presented significant methylation of the liver, kidney, and pancreatic cells and selectivity for these cells against the more general methylating activity of the aglycone analog N-methyl-N-nitrosourea . Streptozocin shows particular activity in the pancreas, and has been used both to induce diabetes in mammals and to treat human pancreatic cancers.
References
1. Bennett, R A., et al., 1981. Cancer research. 41(7): 2786-90.
2. Brentjens, R., et al., 2001. The Surgical Clinics of North America. 81(3): 527-42.
2. Brentjens, R., et al., 2001. The Surgical Clinics of North America. 81(3): 527-42.